PIK3CA and adenocarcinoma: In KRAS-mutated colorectal [92] and lung [93] adenocarcinoma cells, PI3K/AKT pathway activation is dependent on RTK–WT RAS signaling (see Section 3.3), and thus inhibition of RTK signaling should indirectly inhibit PI3K activation.